STAT
APRIL 16, 2024
In the first federal hearing focused on the massive cyberattack on Change Healthcare , lawmakers had many important questions for UnitedHealth, which owns Change: Did it meet Health and Human Services’ cybersecurity performance goals ? Has UnitedHealth exploited physicians’ cash shortfalls caused by the Change outage to acquire struggling practices?
PharmaVoice
APRIL 16, 2024
New clinical trial starts are picking back up, but are still far below their bustling pre-war level.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
APRIL 16, 2024
WASHINGTON – In the last decade, Americans have been sickened by salmonella from cucumbers, listeria from Mexican-style cheese, and E. coli from romaine lettuce. Now, it would seem that Washington is finally getting serious about making sure the Food and Drug Administration has the power to promptly investigate and respond to foodborne outbreaks.
pharmaphorum
APRIL 16, 2024
A smart sensor developed by Adherium has been cleared by the FDA for use with AstraZeneca's asthma inhaler Airsupra and Breztri for COPD.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
APRIL 16, 2024
The face of autism was once predominantly white. No longer. The Centers for Disease Control and Prevention reported last year that the prevalence of autism across all racial and ethnic groups is reaching parity. Among 8-year-olds in particular, autism was more commonly identified among Black, Hispanic and Asian American/Pacific Islander children than among their white counterparts for the first time ever.
pharmaphorum
APRIL 16, 2024
Researchers from the UK have developed an endoscopic device that uses 3D imaging to look at the stiffness of cells and could diagnose cancer earlier.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
APRIL 16, 2024
FDA starts review of GSK’s 5-in-1 meningitis vaccine, cueing up a decision early next year, as it tries to chase down Pfizer's recently-approved Penbraya
STAT
APRIL 16, 2024
Most people know silica as the mysterious contents of desiccation packets found in vitamin bottles, high-end leather purses, clothing, and other items. But for miners and other stone cutters, silica is a serious health hazard, and new rules announced on Tuesday by a U.S. government agency set strict limits on how much of the mineral they can be exposed to.
Express Pharma
APRIL 16, 2024
In the expansive landscape of global healthcare, India has emerged as a pivotal player, shaping the accessibility and affordability of essential medicines worldwide. As the world’s leading supplier of generic drugs, India’s pharmaceutical industry has become a ray of hope for millions as it ensures quality-assured and cost-effective treatments reach those who need them the most.
STAT
APRIL 16, 2024
Intra-Cellular Therapies reported positive results Tuesday from a late-stage clinical trial seeking to expand the use of its antipsychotic medicine Caplyta to patients with major depressive disorder. In the Phase 3 study, Caplyta reduced depressive symptoms by 4.9 points compared to a placebo on the Montgomery-Asberg Depression Rating Scale (MADRS), a widely used, clinician-rated measure of depression severity.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
APRIL 16, 2024
The price ceiling policy has been in place for more than 20 years, but it has neither been very successful nor free of consequences for pharma companies.
STAT
APRIL 16, 2024
“You have a big voice, Dr. Grubbs,” the clinic manager said. I flinched. The last time I heard similar words, they were part of a common refrain that I had encountered often. “You’re too direct.” “Too outspoken.” “Intimidating.” Peers who looked like me encouraged me to put my head down, make myself smaller, endure — and never, ever call out racism.
Pharma Times
APRIL 16, 2024
Solid organ transplantation is used to treat end-stage organ failure, including the kidneys
STAT
APRIL 16, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Today, we dig into Biohaven’s plans and see Humira biosimilar prescriptions shoot up.
Pharma Times
APRIL 16, 2024
Liver cirrhosis, caused by long-term liver damage, is estimated to affect around 100 million people worldwide
STAT
APRIL 16, 2024
Hospitals and medical groups say they’re still reeling from the effects of the cyberattack on a UnitedHealth Group subsidiary, but the massive company at the center of the debacle has so far emerged largely unscathed, with executives on Tuesday praising its strength and resilience. The almost $8 billion UnitedHealth made on operations in the first three months of 2024 was roughly the same as the prior-year period.
pharmaphorum
APRIL 16, 2024
Boehringer Ingelheim says the strongest R&D pipeline in its history is set to deliver 25 new product launches between now and 2030
STAT
APRIL 16, 2024
Top of the morning to you, and a fine one it is. Clear blue skies and cool breezes are currently enveloping the placid Pharmalot campus, where the official mascots are snoozing cozily in their respective corners and the usual din of motor cars is nowhere to be heard. So this calls for a celebratory cup of stimulation. Our choice today is the oh-so tasty hazelnut mocha.
Drug Patent Watch
APRIL 16, 2024
The pharmaceutical industry in China is undergoing a significant transformation with the adoption of artificial intelligence (AI) technology.
STAT
APRIL 16, 2024
The fairness of PIPEs, particularly the preferential sharing of confidential, stock-moving information, is now a legal question. A shareholder is suing Taysha Gene Therapies insiders and a group of health care investment firms for allegedly enriching themselves in a $150 million PIPE transaction that involved delaying the public disclosure of positive results from a gene therapy clinical trial.
PioneerRx
APRIL 16, 2024
It’s the most wonderful time of year for PioneerRx. Catalyst Connect 2024 is rapidly approaching, where pharmacists and other healthcare professionals.
World Pharma News
APRIL 16, 2024
Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, on Sunday April 14 presented results from the 18-month Phase Ib clinical trial for AB-1005, an investigational gene therapy for treating patients with Parkinson's disease (PD).(1,2) The data were presented at the American Academy of Neurology 2024 Annual Meeting in Denver, Colorado, USA.
pharmaphorum
APRIL 16, 2024
Shares in Intra-Cellular Therapies rose after it reported Caplyta was effective for major depressive disorder (MDD), in a phase 3 trial.
Express Pharma
APRIL 16, 2024
Panelists in this video: + Mr Prashant Sharma, CTO, Zydus (Moderator) + Mr Pradipta Kumar Swain, COO, Innoxel Lifesciences + Dr Mahesh Bhalgat, Group CEO, Veeda + Mr Parag Swadia, CEO, Otsuka Pharma + Mr Sudhir Vaid, CMD, Concord Biotech Key Highlights: [1] Vision and values need to be aligned across all levels for organisations to succeed [2] Superhero leaders are overrated and can even prove to be liabilities in the long run.
Pharmaceutical Technology
APRIL 16, 2024
Norgine has sought approval for eflornithine (DFMO) for the treatment of patients with high-risk neuroblastoma (HRNB).
The Pharmacist
APRIL 16, 2024
Almost one in five adults and one in ten children receive a second course of antibiotics for the same respiratory tract infection, researchers have found. Analysis of GP records of more than 900,000 cases of respiratory tract infection across 530 practices in England also found that in half the cases of repeat antibiotic prescribing, the […] The post Significant proportion of RTIs given more than one antibiotic course appeared first on The Pharmacist.
Outsourcing Pharma
APRIL 16, 2024
Qinecsa Solutions (Qinecsa), a lead company in technology-driven end-to-end pharmacovigilance solutions has announced its acquisition of Insife ApS (Insife), a Danish-based firm specializing in innovative pharmacovigilance platforms.
The Pharmacist
APRIL 16, 2024
Any level of passive smoking universally elevates the risk of atrial fibrillation, according to new research presented at the recent European Heart Rhythm Association congress. The researchers examined the association between secondhand smoke exposure and the long-term risk of incident atrial fibrillation, aiming to add to existing research that has established links between passive smoking and […] The post Passive smoking linked to increased risk of atrial fibrillation, new study finds ap
European Pharmaceutical Review
APRIL 16, 2024
Novartis has released new data from the first and only Phase III study to demonstrate significant proteinuria reduction by targeting the complement system in patients with the rare kidney disease IgA nephropathy (IgAN). Pre-specified interim analysis results from the Phase III APPLAUSE-IgAN clinical trial were presented at the 2024 World Congress of Nephrology (WCN).
Outsourcing Pharma
APRIL 16, 2024
Charles River Laboratories International, Inc. has unveiled its Alternative Methods Advancement Project (AMAP), a strong initiative aimed at changing drug discovery and development by exploring alternatives to animal testing.
European Pharmaceutical Review
APRIL 16, 2024
A new global licensing agreement is set to advance development of an oncology biosimilar candidate. Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. and Spain-based biopharmaceutical company mAbxience, have entered into a strategic deal for a drug candidate that is in development for treating multiple indications in the oncology space.
Express Pharma
APRIL 16, 2024
In this video: Prabhat Balyan, Business Development Manager, Ami Polymer Topic: Polymeric solutions for pharmaceutical industry Key Takeaway: Ami Polymer has a range of tubing solutions that serves the pharma industry The post Prabhat Balyan, Business Development Manager, AMI Polymer appeared first on Express Pharma.
Outsourcing Pharma
APRIL 16, 2024
In a recent discussion with Jan Vertommen, vice president and head of commercial development for the small molecules division at Lonza, key insights were shared regarding the pharmaceutical industry's current landscape and future trajectory.
BioPharma Dive
APRIL 16, 2024
Joel Marcus, the longtime head of Alexandria Real Estate Equities, sees few near-term challengers to the established biotech hubs of Boston, San Diego and San Francisco.
Express Pharma
APRIL 16, 2024
Panelists in this video: + Mr SG Belapure, Sr. Technical Advisor, IPA (Moderator) + Dr Viranchi Shah, National President, Indian Drug Manufacturers Association (IDMA) + Mr Vijay Charlu, President, Corona Remedies + Mr Rajiv Gandhi, CEO & MD, Hester Biosciences + Mr Sanjay Sharma, Sr VP & Head-Manufacturing Science and Technology, Zydus Group Key Highlights: [1] An entrepreneurial mindset, conducive business climate and presence of good resources have made Ahmedabad a leading pharma hub
Expert insights. Personalized for you.
354 
Let's personalize your content